This meta-analysis investigated the association between MEG3 levels and distant metastasis (DM), lymph node metastasis (LNM), overall survival (OS), and recurrence-free survival (RFS) of cancer patients. The gene discussed is MEG3; the disease is metastatic malignant neoplasm in the lymph nodes.